SCHEMBL9255512

SCHEMBL9255512

COC(=O)CCNC(=O)c1ccc2c(c1)nc(-c1ccc(C(=N)N)cn1)n2C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.42
HDAC8 Q9BY41 3/20 0.42
HDAC6 Q9UBN7 3/20 0.42
HDAC3 O15379 2/20 0.42
HDAC2 Q92769 2/20 0.42
RIPK2 O43353 1/20 0.40
NAMPT P43490 1/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
PTGER4 P35408 1/20 0.38
NQO2 P16083 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9255028 0.91 ITGB3 (0.47) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL8863519 0.87 HDAC1 (0.52) HDAC1HDAC8HDAC6HDAC3HDAC2
Hydrochloric Acid SCHEMBL9255053 0.86 HDAC1 (0.51) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9252299 0.84 HDAC1 (0.45) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9248410 0.83 F2 (0.42) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9251091 0.83 NPC1 (0.44) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9251150 0.81 HDAC1 (0.50) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9248587 0.81 HDAC6 (0.43) HDAC1HDAC8HDAC6HDAC3HDAC2
Hydrochloric Acid SCHEMBL8863892 0.81 HDAC1 (0.49) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9254163 0.80 KDM4E (0.41) HDAC1HDAC8HDAC6HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5434150-A Anticoagulants, cardiovascular disorders DR. KARL THOMAE GMBH (DE) 1995-07-18 US disclosed
EP-0531883-A1 Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-03-17 EP disclosed